The Pfizer Sanford, NC facility is responsible for manufacturing components for the company’s vaccine portfolio, including Prevnar 13. In addition, the Pfizer Sanford site is home to the state-of-the-art gene therapy manufacturing facility, which provides the ability to produce and supply both clinical and commercial scale quantities of critical life-changing gene therapy medicines to patients living with rare diseases around the world.
This project involved the full Equipment C&Q scope for various equipment including ultrafiltration skids, centrifuges, clean utilities, and ethanol supply and waste systems. Sequence was responsible for developing the strategy and performing integrated functional/performance testing to demonstrate the facility was fit for production of a conjugate vaccine to protect against Neisseria Meningitidis.
Pfizer facility produces Nimenrix which is a conjugate vaccine that helps to provide protection against invasive disease caused by the bacteria Neisseria meningitidis types A, C, W-135 and Y. Source